PEP-Therapy
Michele is an experienced founder and investor in the Life science sector. He has developed and run many successful businesses, including Founder & CEO at Interceptin srl, Surgica Robotica srl, XSurgical Inc.; Chairman of the Board at Angiodroid Srl; Director at Green Bone Ortho srl, WineGrid SA, Sooma Oy, ReJoint srl. He also serves as a Partner at DeBere Capital Partners in London. Michele was previously General Manager, IBM Global Services EMEA. and was Principal at Booz Alllen & Hamilton.
Michele holds an MBA from the Columbia Graduate School of Business in New York and a doctorate in mechanical engineering from the University of Bologna.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.